We are live on ! Find out more
PSC

Piper Sandler & Co Portfolio holdings

AUM $135M
1-Year Est. Return 0.15%
This Fund
S&P 500
This Quarter Est. Return
+1.17%
1 Year Est. Return
+0.15%
3 Year Est. Return
-0.04%
5 Year Est. Return
-7.65%
10 Year Est. Return
–
AUM
$241M
AUM Growth
+$35.7M
Cap. Flow
-$42.5M
Cap. Flow %
-17.64%
Top 10 Hldgs %
73.85%
Holding
186
New
58
Increased
36
Reduced
5
Closed
73

Top Buys

Rank Stock Value
1
WFC.PRL icon
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
+$3.06M
2
SPXU icon
ProShares UltraPro Short S&P 500
SPXU
+$1.85M
3
OCR.PRB
OMNICARE CAP TR II SER B 4% TR PFD INCM EQTY REDM SEC PIERS
OCR.PRB
+$1.59M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$1.18M
5
ATHN
Athenahealth, Inc.
ATHN
+$1.13M

Top Sells

Rank Stock Value
1
SDS icon
ProShares UltraShort S&P500
SDS
+$1.1M
2
EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
+$964K
3
PII icon
Polaris
PII
+$756K
4
FTNT icon
Fortinet
FTNT
+$613K
5
HSTM icon
HealthStream
HSTM
+$590K

Sector Composition

Rank Sector Weight
1 Healthcare 5.56%
2 Technology 5.5%
3 Industrials 1.15%
4 Communication Services 1.07%
5 Consumer Discretionary 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUNE
26
DELISTED
SUNEDISON, INC COM
SUNE
$600K 0.25%
25,000
+10,000
+67% +$215K
BNFT
27
DELISTED
Benefitfocus, Inc.
BNFT
$570K 0.24%
+15,500
New +$463K
TNDM icon
28
Tandem Diabetes Care
TNDM
$1.22B
$568K 0.24%
4,500
+1,500
+50% +$195K
PODD icon
29
Insulet
PODD
$11.6B
$550K 0.23%
+16,500
New +$557K
OREX
30
DELISTED
Orexigen Therapeutics, Inc.
OREX
$548K 0.23%
+7,000
New +$434K
VSLR
31
DELISTED
VIVINT SOLAR, INC.
VSLR
$546K 0.23%
45,000
+20,000
+80% +$189K
BDSI
32
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$504K 0.21%
+48,000
New +$656K
CSIQ icon
33
Canadian Solar
CSIQ
$927M
$501K 0.21%
15,000
+10,000
+200% +$276K
CY
34
DELISTED
Cypress Semiconductor
CY
$494K 0.21%
+35,000
New +$518K
PDFS icon
35
PDF Solutions
PDFS
$1.87B
$493K 0.2%
27,500
+7,500
+38% +$130K
AEGR
36
DELISTED
Aegerion Pharmaceuticals
AEGR
$471K 0.2%
+18,000
New +$458K
LHCG
37
DELISTED
LHC Group LLC
LHCG
$462K 0.19%
+14,000
New +$437K
ZU
38
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
$455K 0.19%
+35,000
New +$580K
MKTO
39
DELISTED
MARKETO INC COM STK (DE)
MKTO
$448K 0.19%
+17,500
New +$522K
HBIO icon
40
Harvard Bioscience
HBIO
$26.7M
$437K 0.18%
+7,500
New +$403K
ATRC icon
41
AtriCure
ATRC
$2.01B
$430K 0.18%
21,000
+4,600
+28% +$89.1K
TSEM icon
42
Tower Semiconductor
TSEM
$22.9B
$425K 0.18%
25,000
+2,500
+11% +$38.3K
OXFD
43
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$419K 0.17%
29,750
+3,750
+14% +$51K
VG
44
DELISTED
Vonage Holdings Corporation
VG
$417K 0.17%
+85,000
New +$380K
TUBE
45
DELISTED
TubeMogul, Inc.
TUBE
$416K 0.17%
+30,113
New +$465K
P
46
DELISTED
Pandora Media Inc
P
$405K 0.17%
25,000
+15,000
+150% +$240K
HTWR
47
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$403K 0.17%
4,592
-1,408
-23% -$120K
KYTH
48
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$401K 0.17%
+8,000
New +$336K
POWR
49
DELISTED
POWERSECURE INTL INC COM STK (DE)
POWR
$395K 0.16%
30,000
+17,500
+140% +$190K
JKS
50
JinkoSolar
JKS
$782M
$385K 0.16%
15,000
+10,000
+200% +$212K
1
2
3 4 5

Similar funds

UOP
University of Pittsburgh Pittsburgh, Pennsylvania $135M AUM 29.36% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
ICM
Isabella Capital Management London $135M AUM
EC
Enhancing Capital Harrisburg, Pennsylvania $135M AUM 25.85% 1-Year Est. Return
AV
Alamea Verwaltungs Edison, New Jersey $135M AUM 36.32% 1-Year Est. Return
GEH
General Equity Holdings Brooklyn, New York $135M AUM 32.96% 1-Year Est. Return
SA
Seneschal Advisors Tacoma, Washington $135M AUM 13.18% 1-Year Est. Return
JAA
Joel Adams & Associates Asheville, North Carolina $135M AUM 10.83% 1-Year Est. Return

Piper Sandler & Co's Q1 2015 Portfolio in Review

As of Q1 2015, Piper Sandler & Co held 186 positions worth $241M, up 17% from $205M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Piper Sandler & Co withdrew a net $42.5M in Q1 2015, closing 73 positions and reducing 5 holdings. Its most notable exit was ProShares UltraShort S&P500, an estimated $1.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 5.6% of assets, up from 5.2% a quarter earlier, followed by Technology and Industrials.

Against the trend, Piper Sandler & Co opened a new position in Wells Fargo 7.5% Non Cumv Perp Conv worth $3.05M.

  • Piper Sandler & Co's largest Q1 2015 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 2,500 shares worth $3.05M.
  • Piper Sandler & Co added most to OMNICARE CAP TR II SER B 4% TR PFD INCM EQTY REDM SEC PIERS in Q1 2015, an estimated $1.59M increase.
  • Piper Sandler & Co's biggest Q1 2015 reduction was Evofem Biosciences, Inc. Common Stock, cutting an estimated $964K.
  • Piper Sandler & Co fully exited ProShares UltraShort S&P500 in Q1 2015, selling an estimated $1.1M.
  • Piper Sandler & Co's ten largest holdings make up 74% of its $241M portfolio in Q1 2015.
  • Piper Sandler & Co opened 58 new positions and closed 73 in Q1 2015.
  • Piper Sandler & Co's portfolio value rose 17% quarter-over-quarter to $241M.

Based on Piper Sandler & Co's 13F filing for Q1 2015, filed 15 May 2015.